Clearside Biomedical, Inc.
Developing therapies for back-of-the-eye diseases via proprietary suprachoroidal delivery.
CLSD | NDAQ
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- United States of America
- Address:
- 900 NORTH POINT PARKWAY, 30005 ALPHARETTA
- Website:
- https://clearsidebio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Clearside Biomedical, Inc. is a biopharmaceutical company focused on developing and delivering therapies for serious back-of-the-eye diseases. The company is a leader in suprachoroidal delivery, utilizing its proprietary, patented SCS Microinjector® to precisely administer treatments to the site of disease. Its key commercial product is XIPERE®, the first and only FDA-approved therapy delivered via the suprachoroidal space for the treatment of macular edema associated with uveitis. Clearside's clinical pipeline is led by CLS-AX, a tyrosine kinase inhibitor (TKI) in a Phase 3 program for wet age-related macular degeneration (Wet AMD). The company leverages its validated technology, extensive clinical experience, and strategic collaborations to advance treatments for various retinal conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Clearside Biomedical, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Clearside Biomedical, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Clearside Biomedical, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
